MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Impact of Age of Symptom Onset in Essential Tremor on Cognition in Elderly Individuals

C. Sangali, G. Pereira, A. Detogni, N. Bruscato, A. Schuh, C. Rieder (Porto Alegre, Brazil)

Meeting: 2025 International Congress

Keywords: Cognitive dysfunction, Essential tremor(ET)

Category: Tremor

Objective: To evaluate the association between age of symptom onset and cognitive function in elderly individuals with Essential Tremor (ET).

Background: ET is one of the most common causes of tremor in older adults and is associated with various features that can affect functionality, including cognitive impairments. The onset of symptoms in ET follows a bimodal distribution, with two peaks: early and late. Late-onset ET may be linked to cognitive decline and dementia in affected individuals.

Method: This was a cross-sectional study with 71 older individuals with ET. To analyze the differences between elderly individuals with early onset of symptoms and those whose symptoms began with aging, the sample was divided into two groups: AOS<50 (Age of Onset of Symptoms <50 years) consisting of 19 individuals who showed symptoms before the age of fifty, and AOS>50, with 52 individuals who had the onset of symptoms after this age range. To assess cognitive function, the Montreal Cognitive Assessment (MoCA) scale was used. In the statistical analysis, for numerical variables that were not normally distributed, the Mann-Whitney U test was employed, while the t-test was used for normally distributed variables.

Results: The AOS<50 group had an average age of 33.8±13.8 years at symptom onset, while the AOS>50 group had an average of 65.8±7.9 years. No significant differences were observed in age between the two groups or in Body Mass Index (BMI). On the MoCA scale, the AOS<50 group scored significantly higher (p=0.005), indicating better cognitive performance compared to the AOS>50 group (Table 1).

Conclusion: The findings highlight that individuals with late-onset tremor symptoms had lower scores on the cognitive test. These patients possibly experience a faster progression due to reduced cognitive reserve and neuronal loss associated with aging. It is suggested that, despite a longer disease duration, individuals with an earlier onset of symptoms exhibit preserved cognitive functions.

Table 1

Table 1

To cite this abstract in AMA style:

C. Sangali, G. Pereira, A. Detogni, N. Bruscato, A. Schuh, C. Rieder. Impact of Age of Symptom Onset in Essential Tremor on Cognition in Elderly Individuals [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/impact-of-age-of-symptom-onset-in-essential-tremor-on-cognition-in-elderly-individuals/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/impact-of-age-of-symptom-onset-in-essential-tremor-on-cognition-in-elderly-individuals/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley